# Tissue Collection for Correlation Between ATM Alterations by Next-Generation Sequencing and ATM Loss-of-Protein

> **NCT04976803** · — · COMPLETED · sponsor: **Artios Pharma Ltd** · enrollment: 229 (actual)

## Conditions studied

- Solid Tumor, Unspecified, Adult

## Interventions

- **OTHER:** Determination of ATM alteration status.

## Key facts

- **NCT ID:** NCT04976803
- **Lead sponsor:** Artios Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-28
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 229 (ACTUAL)
- **Last updated:** 2022-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04976803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04976803, "Tissue Collection for Correlation Between ATM Alterations by Next-Generation Sequencing and ATM Loss-of-Protein". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04976803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*